Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration

被引:62
作者
Sigurdsson, HH
Stefánsson, E
Gudmundsdóttir, E
Eysteinsson, T
Thorsteinsdóttir, M
Loftsson, T
机构
[1] Univ Iceland, Fac Pharm, IS-107 Reykjavik, Iceland
[2] Univ Reykjavik, Hosp Landspitalinn, Fac Med, Dept Ophthalmol, IS-101 Reykjavik, Iceland
[3] Univ Iceland, Fac Med, Dept Physiol, IS-101 Reykjavik, Iceland
[4] Encode Inc, IS-110 Reykjavik, Iceland
关键词
dorzolamide; cyclodextrin; ocular drug delivery; rabbits; tissue distribution;
D O I
10.1016/j.jconrel.2004.10.004
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Due to limited aqueous solubility of dorzolamide at physiologic pH, the pH of Trusopt(R) eye drops (cont. 2% dorzolamide) has to be kept at about 5.65, and to increase the topical bioavailability of the drug from Trusopt(R) the contact time of the drug with the eye surface is increased by increasing the viscosity of the eye drops to 100 cps. This low pH and high viscosity can lead to local irritation. In this study, dorzolamide hydrochloride was formulated as 2% and 4% low viscosity solutions (viscosity 3 to 5 cps) containing randomly methylated beta-cyclodextrin at pH 7.45. These formulations were evaluated in rabbits. The animals were sacrificed at various time points after topical administration of the drug and the dorzolamide concentration determined in the different parts of the eye. Trusopt(R) was used as a reference standard. The topical availability of dorzolamide from the cyclodextrin-containing eye drops appeared to be comparable to that from Trusopt(R) and the drug reached retina and optic nerve to give measurable concentrations for at least 8 h after administration of the eye drops. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 31 条
  • [1] COMPARISON OF CONCENTRATION-TIME PROFILES OF LEVOBUNOLOL AND TIMOLOL IN ANTERIOR AND POSTERIOR OCULAR-TISSUES OF ALBINO RABBITS
    ACHEAMPONG, AA
    BREAU, A
    SHACKLETON, M
    LUO, W
    LAM, S
    TANGLIU, DDS
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1995, 11 (04) : 489 - 502
  • [2] ARAIE M, 1982, JPN J OPHTHALMOL, V26, P248
  • [3] Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study
    Bergstrand, IC
    Heijl, A
    Harris, A
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (02): : 176 - 182
  • [4] BLAUG SM, 1965, AM J HOSP PHARM, P662
  • [5] The effects of antiglaucoma and systemic medications on ocular blood flow
    Costa, VP
    Harris, A
    Stefánsson, E
    Flammer, J
    Krieglstein, GK
    Orzalesi, N
    Heijl, A
    Renard, JP
    Serra, LM
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2003, 22 (06) : 769 - 805
  • [6] Recent developments in ophthalmic drug delivery
    Ding, SL
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08): : 328 - 335
  • [7] GUDMUNDSDOTTIR E, 2000, DEX EYE DROP SOL 10
  • [8] Harris A, 1996, ACTA OPHTHALMOL SCAN, V74, P569
  • [9] OCULAR ABSORPTION FOLLOWING TOPICAL DELIVERY
    JARVINEN, K
    JARVINEN, T
    URTTI, A
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (01) : 3 - 19
  • [10] Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries
    Josefsson, A
    Sigurdsson, SB
    Bang, K
    Eysteinsson, T
    [J]. EXPERIMENTAL EYE RESEARCH, 2004, 78 (02) : 215 - 221